Age considerations when vaccinating against HPV
- 1 May 2008
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 109 (2) , S40-S47
- https://doi.org/10.1016/j.ygyno.2008.02.002
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisThe Lancet Infectious Diseases, 2007
- Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialThe Lancet, 2007
- Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital DiseasesNew England Journal of Medicine, 2007
- HPV Vaccination — More Answers, More QuestionsNew England Journal of Medicine, 2007
- Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical LesionsNew England Journal of Medicine, 2007
- American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its PrecursorsCA: A Cancer Journal for Clinicians, 2007
- Chapter 14: HPV vaccine introduction in industrialized countriesVaccine, 2006
- A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent WomenThe Journal of Infectious Diseases, 2005
- Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University StudentsAmerican Journal of Epidemiology, 2003
- Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort studyPublished by Elsevier ,2001